Dr. Hagop M. Kantarjian, a member of the Clinical Advisory Board of Rockville biotech firm Ascentage Pharma, has received the highest honor bestowed by the American Society of Clinical Oncology (ASCO). The organization presented Kantarjian the David A. Karnofsky Memorial Award "for his lifelong contributions to leukemia clinical research and his dedication to improving the lives of patients" at its annual meeting, which is taking place through tomorrow in Chicago. Those who have received the Karnofsky award since its inception in 1970 have been oncologists who made outstanding contributions to cancer research, diagnosis, or treatment.
"Dr. Kantarjian has dedicated his life to saving and enhancing the lives of patients with leukemia, renewing hope to millions of patients with unmet medical needs," Ascentage Pharma Chairman Dajun Yang, MD, PhD said in a statement this morning. "For decades, he has been at the forefront of the oncology community's efforts to end cancer. We are privileged that Dr. Kantarjian has chosen to share his wise counsel with our organization while serving with honor and distinction on the Ascentage Pharma Clinical Advisory Board."
Ascentage Pharma was founded in 2009 in Suzhou, China. Its American office is in Three Irvington Centre, at 700 King Farm Boulevard in Rockville.
No comments:
Post a Comment